Parkinson’s disease is well-known fit its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking. Less spring known is that Parkinson’s shares other symptoms with narcolepsy, a take rumpus characterized by rash and uncontrollable episodes of deep sleep, bare fatigue and general sleep tangle.
Seldom a side of UCLA and Veterans Affairs researchers think they know why the two disorders share something in common: Parkinson’s disease patients sooner a be wearing taxing devastation to the same poor group of neurons whose loss causes narcolepsy. The findings propose a different clinical undoubtedly of treatment quest of people suffering with Parkinson’s that may ameliorate their sleep symptoms.
In their report in the June issue of the periodical Brain and currently online, Jerry Siegel, professor of psychiatry and biobehavioral sciences at the Semel Institute for Neuroscience and Human Behavior at UCLA, assistant resident neurobiologist Thomas C. Thannickal and associate research physiologist Yuan-Yang Lai include determined that Parkinson’s murrain patients have a loss of up to 60 percent of imagination cells containing the peptide hypocretin. In 2000, this same group of UCLA researchers leading identified the case of narcolepsy as a loss of hypocretin, thought to be urgent in regulating the sleep cycle. This latest scrutinize points to a common ground in the course of the sleep disorders associated with these two diseases and suggests that treatment of Parkinson’s disorder patients with hypocretin or hypocretin analogs may cancel these symptoms.
More than 1 million people in the U.S. possess been diagnosed with Parkinson’s disease, and approximately 20 million worldwide. (The percentage of those afflicted increases with age.) Narcolepsy affects approximately one in 2,000 individuals — helter-skelter 150,000 in the United States and 3 million worldwide. Its main symptoms are beauty sleep attacks, nighttime sleeplessness and cataplexy, the hasty loss of skeletal muscle tone without loss of consciousness; that is, although the person cannot talk or rouse, they are otherwise in a state of high alertness, feeling, hearing and remembering everything that is affluent on around them.
“When we think of Parkinson’s, the gold medal thingumabob that comes to temperament are the motor disorders associated with it,” said Siegel, who is also chief of neurobiology scrutinize at the Sepulveda Veterans Affairs Medical Center in Mission Hills, Calif. “But be in the land of Nod disruption is a major problem in Parkinson’s, time more upsetting than its motor symptoms. And most Parkinson’s patients have daytime nap attacks that take after narcoleptic sleep attacks.”
In fact, said Siegel, Parkinson’s disease is repeatedly preceded and accompanied by daytime snooze attacks, nocturnal insomnia, REM sleep disorderliness, hallucinations and depression. All of these symptoms are also present in narcolepsy.
In the study, the researchers examined 16 human brains from cadavers five from conformist adults and 11 in various stages of Parkinson’s and set up an increasing negative cash flow death of hypocretin cells (Hcrt) with disease progression. In fact, said Siegel, the later stages of Parkinson’s were “characterized by a massive loss of the Hcrt neurons. That leads us to be convinced of the loss of Hcrt cells may be a cause of the narcolepsy-congenial symptoms of Parkinson’s and may be ameliorated by treatments aimed at reversing the Hcrt deficit.”
Funding for the study was provided by the Patriotic Institutes of Strength and the Medical Digging Service of the U.S. Be influenced of Veterans Affairs.
The Semel Society appropriate for Neuroscience and Kind Behavior at UCLA is an interdisciplinary analyse and cultivation institute steadfast to the covenant of complex human behavior, including the genetic, biological, behavioral and sociocultural underpinnings of normal behavior and the causes and consequences of neuropsychiatric disorders. In addition to conducting fundamental research, the institute faculty seeks to develop effective treatments for neurological and psychiatric disorders, improve access to disturbed haleness services, and shape national health principles regarding neuropsychiatric disorders.
University of California, Los Angeles (UCLA), Fettle Sciences
924 Westwood Blvd., Ste. 350
Los Angeles, CA 90095
United States
http://www.ucla.edu




